Timing of Pharmacotherapy Initiation for Patients with Gestational Diabetes

Forgot your password?

Select specialty

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

By INOVA FEATURING Anna Palatnik

January 5, 2024

Feat. S. Shadid

University of Colorado Department of Medicine

Feat. J. Okemah

Feat. M. Heyman

Feat. F. Pasquel

Diana Isaacs

Keck School of Medicine of USC

Robert Busch

Michigan Medicine - Podiatry

G. Rothenberg

Jennifer Rosselli

S. Twillmann

Krista Varady

Michigan Medicine - Podiatry

European Menopause and Andropause Society

Login

Login

Join VuMedi

Timing of Pharmacotherapy Initiation for Patients with Gestational Diabetes

Discover the MOA of an Incretin Medication for T2D

A Journey Through Clinical Efficacy and Safety Data Comparing Two In…

Recommended

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Advancing Type 2 Diabetes Care with Omnipod® 5

Optimizing Omnipod® 5 for Better Patient Outcomes (featuring Jennife…

Labs to Check on Semaglutide or Tirzepatide

Mind over diabetes: a psychologist’s take on the freedom of Omnipod®…

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Tirzepatide Updates

Weightloss in Menopause

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

The Differences Between the Products of GLP1's and GLP/GIPs

Could It Be Cushing’s? Rethinking Diabetes Management with the CATAL…

Optimizing Omnipod 5 Therapy: Case Studies - TCOYD

Diabetic Peripheral Neuropathy: A Review of Clinical Practice Guidel…

Switch, Change, Rearrange: Diabetes Medication Transitions, De-presc…

Wegovy 2024 Updates

ADA 2022 Flipping the Metabolic Switch: Intermittent Fasting as a We…

Perioperative Management of Anticoagulants: Podiatry Education Series

Mounjaro Update 2024

Effects of Menopause Hormone Treatment on Atherosclerosis Progression